Bhatia Jasvinder Kaur, Malik Ajay, Chaudhary Tripta, Gopal Arun, Boruah Dibyajyoti, Singh Brajesh
Department of Pathology, Command Hospital (Eastern Command), Kolkata, West Bengal, India.
Department of Pathology, Armed Forces Medical College, Pune, Maharashtra, India.
J Microsc Ultrastruct. 2022 Sep 6;11(4):214-219. doi: 10.4103/jmau.jmau_51_21. eCollection 2023 Oct-Dec.
Tumor microenvironment is emerging as a critical factor for progression of breast cancer. Tumor-associated macrophages (TAMs) play an important role in promoting tumor growth.
This study was aimed at correlation of number density (ND) of TAMs with invasive ductal carcinoma (IDC) grading utilizing an image morphometric technique. We also sought to compare the TAMs and ND in the tumoral area and stromal region. We also explored the relationship between the clinical and pathological prognostic parameters.
The study included 75 cases of IDC that had undergone modified radical mastectomy. The Institutional Ethics Committee approved the study. Samples were classified as Grade 1, 2, and 3. Cases were graded as per the modified Bloom and Richardson criterion. Mean with standard deviation was calculated for each group. We utilized CD68 and CD163 immunostained sections for determining the ND of TAMs. TAMs were evaluated using computerized digital photomicrograph system with image analyzing software. ND was defined as the number of TAMs in total number of TAMs in five high-power fields/total area of five fields. ND was calculated separately in tumor and tumor stroma (TS). Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2/neu (HER2/neu) were scored in accordance with recommendations. Ki-67 was scored as per the recommended guidelines.
Data were tabulated in Microsoft Excel. SPSS version 20.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. To determine the relationship between macrophage density and clinicopathologic parameters, we used the independent -test. To determine the differences in the parameters, analysis of variance (ANOVA) was utilized.
Age of the patients ranged from 34 to 58 years (mean: 55.5). One-way ANOVA between various grades of tumor indicating significant differences in terms of CD68 and CD163 densities in tumor and stroma ( < 0.0001). i.e., significant increased density of CD68 and CD163 was observed in Grade 3 tumor as compared to other two groups. A greater histological grade, ER, PR negative status, and a high Ki-67 index were all associated with TAM ND. There was no relation to HER2/neu status. Result of unpaired -test indicates increased density in stroma as compared to tumor among various grades of IDC.
We analyzed images with a software using photographs of the stained slides. This helped in quantitative analysis of TAMs on the CD68 and CD163 stained sections. This approach standardizes and reproducibly counts TAMs per unit area. We found significant difference between the number densities of TAMs in grades of invasive breast carcinoma. There were statistically significant differences in numerical densities of TAMs with ER, PR negativity, and Ki-67. There was no correlation with HER2/neu. Densities of CD68 and CD163 densities are more prevalent in TS as compared to intratumoral region.
肿瘤微环境正成为乳腺癌进展的关键因素。肿瘤相关巨噬细胞(TAM)在促进肿瘤生长中起重要作用。
本研究旨在利用图像形态计量技术探讨TAM的数量密度(ND)与浸润性导管癌(IDC)分级的相关性。我们还试图比较肿瘤区域和基质区域的TAM及ND。我们还探讨了临床和病理预后参数之间的关系。
本研究纳入75例行改良根治性乳房切除术的IDC病例。该研究经机构伦理委员会批准。样本分为1级、2级和3级。病例根据改良的Bloom和Richardson标准分级。计算每组的均值及标准差。我们使用CD68和CD163免疫染色切片来确定TAM的ND。使用带有图像分析软件的计算机化数字显微摄影系统评估TAM。ND定义为五个高倍视野中TAM的总数/五个视野的总面积。分别在肿瘤和肿瘤基质(TS)中计算ND。雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2/neu(HER2/neu)根据推荐标准进行评分。Ki-67根据推荐指南进行评分。
数据录入Microsoft Excel表格。使用SPSS 20.0版(美国纽约州阿蒙克市IBM公司)进行统计分析。为确定巨噬细胞密度与临床病理参数之间的关系,我们使用独立t检验。为确定参数差异,采用方差分析(ANOVA)。
患者年龄范围为34至58岁(平均:55.5岁)。不同肿瘤分级之间的单因素方差分析表明,肿瘤和基质中CD68和CD163密度存在显著差异(P<0.0001)。即,与其他两组相比,3级肿瘤中CD68和CD163密度显著增加。更高的组织学分级、ER和PR阴性状态以及高Ki-67指数均与TAM ND相关。与HER2/neu状态无关。非配对t检验结果表明,在不同分级的IDC中,基质中的密度高于肿瘤。
我们使用染色玻片的照片通过软件分析图像。这有助于对CD68和CD163染色切片上的TAM进行定量分析。这种方法标准化并可重复地计算每单位面积的TAM。我们发现浸润性乳腺癌分级中TAM的数量密度存在显著差异。TAM的数量密度与ER、PR阴性和Ki-67之间存在统计学显著差异。与HER2/neu无相关性。与肿瘤内区域相比,CD68和CD163密度在TS中更普遍。